Cargando…

Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016

AIMS: To compare the population proportion at high risk of cardiovascular disease (CVD) using the Norwegian NORRISK 1 that predicts 10-year risk of CVD mortality and the Norwegian national guidelines from 2009, with the updated NORRISK 2 that predicts 10-year risk of both fatal and non-fatal risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilsen, Amalie, Hanssen, Tove Aminda, Lappegård, Knut Tore, Eggen, Anne Elise, Løchen, Maja-Lisa, Selmer, Randi Marie, Njølstad, Inger, Wilsgaard, Tom, Hopstock, Laila A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407203/
https://www.ncbi.nlm.nih.gov/pubmed/34462328
http://dx.doi.org/10.1136/openhrt-2021-001777
_version_ 1783746603961548800
author Nilsen, Amalie
Hanssen, Tove Aminda
Lappegård, Knut Tore
Eggen, Anne Elise
Løchen, Maja-Lisa
Selmer, Randi Marie
Njølstad, Inger
Wilsgaard, Tom
Hopstock, Laila A
author_facet Nilsen, Amalie
Hanssen, Tove Aminda
Lappegård, Knut Tore
Eggen, Anne Elise
Løchen, Maja-Lisa
Selmer, Randi Marie
Njølstad, Inger
Wilsgaard, Tom
Hopstock, Laila A
author_sort Nilsen, Amalie
collection PubMed
description AIMS: To compare the population proportion at high risk of cardiovascular disease (CVD) using the Norwegian NORRISK 1 that predicts 10-year risk of CVD mortality and the Norwegian national guidelines from 2009, with the updated NORRISK 2 that predicts 10-year risk of both fatal and non-fatal risk of CVD and the Norwegian national guidelines from 2017. METHODS: We included participants from the Norwegian population-based Tromsø Study (2015–2016) aged 40–69 years without a history of CVD (n=16 566). The total proportion eligible for intervention was identified by NORRISK 1 and the 2009 guidelines (serum total cholesterol ≥8 mmol/L, systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg) and NORRISK 2 and the 2017 guidelines (serum total cholesterol ≥7 mmol/L, low density lipoprotein (LDL) cholesterol ≥5 mmol/L, systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg). RESULTS: The total proportion at high risk as defined by a risk score was 12.0% using NORRISK 1 and 9.8% using NORRISK 2. When including single risk factors specified by the guidelines, the total proportion eligible for intervention was 15.5% using NORRISK 1 and the 2009 guidelines and 18.9% using NORRISK 2 and the 2017 guidelines. The lowered threshold for total cholesterol and specified cut-off for LDL cholesterol stand for a large proportion of the increase in population at risk. CONCLUSION: The population proportion eligible for intervention increased by 3.4 percentage points from 2009 to 2017 using the revised NORRISK 2 score and guidelines.
format Online
Article
Text
id pubmed-8407203
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-84072032021-09-16 Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016 Nilsen, Amalie Hanssen, Tove Aminda Lappegård, Knut Tore Eggen, Anne Elise Løchen, Maja-Lisa Selmer, Randi Marie Njølstad, Inger Wilsgaard, Tom Hopstock, Laila A Open Heart Cardiac Risk Factors and Prevention AIMS: To compare the population proportion at high risk of cardiovascular disease (CVD) using the Norwegian NORRISK 1 that predicts 10-year risk of CVD mortality and the Norwegian national guidelines from 2009, with the updated NORRISK 2 that predicts 10-year risk of both fatal and non-fatal risk of CVD and the Norwegian national guidelines from 2017. METHODS: We included participants from the Norwegian population-based Tromsø Study (2015–2016) aged 40–69 years without a history of CVD (n=16 566). The total proportion eligible for intervention was identified by NORRISK 1 and the 2009 guidelines (serum total cholesterol ≥8 mmol/L, systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg) and NORRISK 2 and the 2017 guidelines (serum total cholesterol ≥7 mmol/L, low density lipoprotein (LDL) cholesterol ≥5 mmol/L, systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg). RESULTS: The total proportion at high risk as defined by a risk score was 12.0% using NORRISK 1 and 9.8% using NORRISK 2. When including single risk factors specified by the guidelines, the total proportion eligible for intervention was 15.5% using NORRISK 1 and the 2009 guidelines and 18.9% using NORRISK 2 and the 2017 guidelines. The lowered threshold for total cholesterol and specified cut-off for LDL cholesterol stand for a large proportion of the increase in population at risk. CONCLUSION: The population proportion eligible for intervention increased by 3.4 percentage points from 2009 to 2017 using the revised NORRISK 2 score and guidelines. BMJ Publishing Group 2021-08-30 /pmc/articles/PMC8407203/ /pubmed/34462328 http://dx.doi.org/10.1136/openhrt-2021-001777 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Cardiac Risk Factors and Prevention
Nilsen, Amalie
Hanssen, Tove Aminda
Lappegård, Knut Tore
Eggen, Anne Elise
Løchen, Maja-Lisa
Selmer, Randi Marie
Njølstad, Inger
Wilsgaard, Tom
Hopstock, Laila A
Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016
title Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016
title_full Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016
title_fullStr Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016
title_full_unstemmed Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016
title_short Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016
title_sort change in cardiovascular risk assessment tool and updated norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the tromsø study 2015–2016
topic Cardiac Risk Factors and Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407203/
https://www.ncbi.nlm.nih.gov/pubmed/34462328
http://dx.doi.org/10.1136/openhrt-2021-001777
work_keys_str_mv AT nilsenamalie changeincardiovascularriskassessmenttoolandupdatednorwegianguidelinesforcardiovasculardiseaseinprimarypreventionincreasethepopulationproportionatriskthetromsøstudy20152016
AT hanssentoveaminda changeincardiovascularriskassessmenttoolandupdatednorwegianguidelinesforcardiovasculardiseaseinprimarypreventionincreasethepopulationproportionatriskthetromsøstudy20152016
AT lappegardknuttore changeincardiovascularriskassessmenttoolandupdatednorwegianguidelinesforcardiovasculardiseaseinprimarypreventionincreasethepopulationproportionatriskthetromsøstudy20152016
AT eggenanneelise changeincardiovascularriskassessmenttoolandupdatednorwegianguidelinesforcardiovasculardiseaseinprimarypreventionincreasethepopulationproportionatriskthetromsøstudy20152016
AT løchenmajalisa changeincardiovascularriskassessmenttoolandupdatednorwegianguidelinesforcardiovasculardiseaseinprimarypreventionincreasethepopulationproportionatriskthetromsøstudy20152016
AT selmerrandimarie changeincardiovascularriskassessmenttoolandupdatednorwegianguidelinesforcardiovasculardiseaseinprimarypreventionincreasethepopulationproportionatriskthetromsøstudy20152016
AT njølstadinger changeincardiovascularriskassessmenttoolandupdatednorwegianguidelinesforcardiovasculardiseaseinprimarypreventionincreasethepopulationproportionatriskthetromsøstudy20152016
AT wilsgaardtom changeincardiovascularriskassessmenttoolandupdatednorwegianguidelinesforcardiovasculardiseaseinprimarypreventionincreasethepopulationproportionatriskthetromsøstudy20152016
AT hopstocklailaa changeincardiovascularriskassessmenttoolandupdatednorwegianguidelinesforcardiovasculardiseaseinprimarypreventionincreasethepopulationproportionatriskthetromsøstudy20152016